O Shaughnessy Asset Management LLC Acquires Shares of 1,176,604 Bausch Health Companies Inc (BHC)

O Shaughnessy Asset Management LLC acquired a new stake in shares of Bausch Health Companies Inc (NYSE:BHC) in the third quarter, Holdings Channel reports. The firm acquired 1,176,604 shares of the company’s stock, valued at approximately $29,915,000.

Other large investors also recently made changes to their positions in the company. NEXT Financial Group Inc purchased a new position in shares of Bausch Health Companies in the third quarter worth $101,000. Steward Partners Investment Advisory LLC purchased a new position in shares of Bausch Health Companies in the third quarter worth $106,000. Polaris Greystone Financial Group LLC purchased a new position in shares of Bausch Health Companies in the third quarter worth $107,000. Quadrant Capital Group LLC purchased a new position in shares of Bausch Health Companies in the third quarter worth $118,000. Finally, Bedel Financial Consulting Inc. purchased a new position in shares of Bausch Health Companies in the third quarter worth $129,000. Institutional investors and hedge funds own 42.90% of the company’s stock.

Shares of BHC opened at $27.20 on Friday. The company has a debt-to-equity ratio of 7.55, a current ratio of 1.14 and a quick ratio of 0.89. Bausch Health Companies Inc has a one year low of $13.86 and a one year high of $28.45. The firm has a market capitalization of $9.48 billion, a P/E ratio of 7.10, a PEG ratio of 0.37 and a beta of -0.28.

Bausch Health Companies (NYSE:BHC) last issued its quarterly earnings data on Tuesday, November 6th. The company reported $1.15 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.84 by $0.31. Bausch Health Companies had a positive return on equity of 32.19% and a negative net margin of 40.41%. The company had revenue of $2.14 billion during the quarter, compared to analyst estimates of $2.09 billion. The business’s revenue was down 3.7% compared to the same quarter last year. Equities research analysts predict that Bausch Health Companies Inc will post 3.7 EPS for the current fiscal year.

In other news, CFO Paul Herendeen acquired 10,000 shares of the business’s stock in a transaction that occurred on Friday, September 14th. The stock was bought at an average price of $22.61 per share, with a total value of $226,100.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Joseph C. Papa acquired 30,000 shares of the business’s stock in a transaction that occurred on Friday, September 14th. The stock was purchased at an average cost of $22.32 per share, with a total value of $669,600.00. The disclosure for this purchase can be found here. Insiders purchased 165,000 shares of company stock valued at $3,890,700 in the last ninety days. 11.54% of the stock is currently owned by corporate insiders.

Several research analysts have recently weighed in on BHC shares. ValuEngine cut Bausch Health Companies from a “hold” rating to a “sell” rating in a research note on Friday, September 7th. Cantor Fitzgerald restated a “buy” rating and issued a $32.00 price target on shares of Bausch Health Companies in a research note on Wednesday, September 12th. Zacks Investment Research upgraded Bausch Health Companies from a “hold” rating to a “buy” rating and set a $31.00 price target for the company in a research note on Wednesday, October 3rd. Mizuho restated a “buy” rating and issued a $35.00 price target on shares of Bausch Health Companies in a research note on Monday, October 8th. Finally, Piper Jaffray Companies upgraded Bausch Health Companies from an “underweight” rating to a “neutral” rating and boosted their price target for the stock from $16.00 to $19.00 in a research note on Thursday, September 13th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $27.55.

ILLEGAL ACTIVITY NOTICE: “O Shaughnessy Asset Management LLC Acquires Shares of 1,176,604 Bausch Health Companies Inc (BHC)” was first posted by WKRB News and is the sole property of of WKRB News. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.wkrb13.com/2018/11/10/o-shaughnessy-asset-management-llc-acquires-shares-of-1176604-bausch-health-companies-inc-bhc.html.

Bausch Health Companies Company Profile

Bausch Health Companies Inc develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. It offers dermatology products that treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis, cold sores, athlete's foot, nail fungus, and other dermatoses, as well as provides aesthetic medical devices, which address various conditions, including facial wrinkles, acne, pigmentation conditions, body sculpting, skin tightening, and laser hair removal.

Featured Article: Investing in Growth Stocks

Want to see what other hedge funds are holding BHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bausch Health Companies Inc (NYSE:BHC).

Institutional Ownership by Quarter for Bausch Health Companies (NYSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply